Pharmacological inhibition of PAI-1 reduces immunosuppressive cell populations such as TAMs and CAFs, enhances infiltration of cytotoxic T cells, and, in combination with anti-PD-1 Ab therapy, induces tumor regression [9]. This evidence concerns the gene SERPINE1 and neoplasm.